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A 65-year-old man was referred for evaluation 
of acute onset of fever, productive cough and 
dyspnoea. He had previously received a diagnosis 
of laryngeal carcinoma, which had been treated 
with laryngectomy and bilateral laterocervical 
lymphadenectomy, followed by chemotherapy. He 
underwent plastic surgery of the laryngocutaneous 
fistula, and a positron emission tomography (PET)-
computed tomography (CT) examination performed 
during follow-up showed 18-FDG (2-fluoro-2-deoxy-
d-glucose) lung uptake in the apical right portion. He 
had a smoking history and his regular medications 
included dexamethasone, metoclopramide, 
omeprazole, furosemide, cholecalciferol and 
pregabalin. He had a history of chronic kidney failure 
and thyroid goitre, no family history of pulmonary 
disease or malignancy, nor of drug allergies.
Physical examination 
findings
The patient’s physical examination findings were as 
follows: respiratory rate 28 breaths·min−1; heart rate 
71 beats·min−1; blood pressure 130/80 mmHg; 
peripheral capillary oxygen saturation by pulse 
oximeter on ambient air 94%; body temperature 
38°C. He was eupnoeic at rest. Physical examination 
revealed bilateral widespread wheezing and 
rhonchi in the lower lobes. The cardiopulmonary 
evaluation produced unremarkable results. 
Palpable lymphadenopathy was noted in the right 
laterocervical region. Peripheral bilateral oedema 
was also present.
Diagnostic studies
A complete blood count with differential and 
chemistry panel showed normal results. The 
blood gas analysis revealed the following findings: 
pH 7.50, carbon dioxide tension 29.4 mmHg, 
oxygen tension 62.5 mmHg, bicarbonate 
22.4 mmol·L−1, arterial oxygen saturation 94% 
on ambient air.
A non-contrast CT-scan showed confluent 
areas of parenchymal consolidation associated 
with bilateral ground-glass opacities (figure 1). 
Bronchoscopy with bronchoalveolar lavage (BAL) 
revealed the presence of Klebsiella pneumoniae 
and Pseudomonas aeruginosa; staining for acid-fast 
bacteria produced negative results. Cytology showed 
alveolar macrophages and granulocytes without 
malignant cells. Laboratory tests (blood cultures, 
urinalysis, Legionella urinary antigen, serological 
IgM and IgG for cytomegalovirus, Epstein–Barr virus, 
herpes simplex virus 1–2, Mycoplasma, Chlamydia) 
were all negative.
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The infiltrates seen on the CT are consistent 
both with a pattern of interstitial lung disease and 
an endoalveolar refill. Based on the BAL findings, 
the hypothesis of respiratory infection was the 
most probable. Therefore, antibiotic treatment 
with meropenem and linezolid i.v. was started. 
Despite this, the patient remained febrile (body 
temperature of 39°C) and the cough persisted 
unchanged. As a consequence, the current 
regimen was stopped and caspofungin, ceftazidime 
and ciprofloxacin were added. After 5 days of 
treatment, the microbiological sputum culture 
turned negative. However, the clinical conditions 
remained unchanged, thus ruling out the previous 
hypothesis of infectious aetiology.
a) b) c)
Figure 1 a–c) CT scan of the chest demonstrating multiple confluent areas of parenchymal consolidation associated with 




Which procedure should be performed?
a) Transbronchial biopsy
b) Surgical lung biopsy
c) Magnetic resonance imaging
d) Echocardiogram
e) None of the above
Task 1
What is the most likely diagnosis based on the 
imaging shown in figure 1?
a) Pulmonary infection
b) Metastasis of nonpulmonary lung cancer
c) Acute distress respiratory syndrome
d) Pulmonary eodema
e) All the above
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Which diagnosis would you suggest?
a) Diffuse alveolar damage
b) Pulmonary adenomas





Figure 2 Stained sections obtained from a formalin-fixed paraffin-embedded specimen of transbronchial biopsy treated 
with haematoxylin–eosin. a) Specimen showing the presence of interstitial fibrosis and mild inflammation with few lympho-
cytes, alveolar lining cell hyperplasia and some lipid-laden foamy macrophages. Original magnification 200x. b) Specimen 
showing the presence of some lipid-laden foamy macrophages. Original magnification 600x. c) Specimen showing the 
presence of interstitial fibrosis and mild inflammation with few lymphocytes, alveolar lining cell hyperplasia and some 
lipid-laden foamy macrophages. Original magnification 400x.
Answer 3
d.
On the basis of the clinical history and the 
course of the disease, the occurrence of lung 
metastasis related to the progression of the 
primary neoplasia was suspected. Surgical 
biopsy was excluded because of the invasive 
nature of the procedure. Bronchoscopy with 
ultrasound transbronchial biopsy appeared 
to be the most suitable procedure and was 
performed. The macroscopic appearance of 
tracheal aspirate revealed a whitish and turbid 
fluid. The differential cell count of the BAL revealed 
alveolar macrophages, granulocytes and epithelial 
cells, and no evidence of malignant cells. The 
histological examination is shown in figure 2.
The histological picture was suggestive of 
lipoid pneumonia (LP), mainly based on the 
detection of foamy alveolar macrophages due to 
the intracellular accumulation of lipid vacuoles. 
By carefully reviewing the exposure history, we 
found that the patient had regularly applied 
oil-based products through the tracheostomy 
to moisturise the cannula. The patient stopped 
his use of lubricant oil and oral corticosteroid 
therapy was initiated at the dose of 0.5 mg·kg−1 
and gradually tapered off. This led to a marked 
improvement in respiratory symptoms, and 
the patient was discharged after 20 days. He 
was instructed to refrain from using oil-based 
substances, and at the follow-up visit 1 month 
after discharge his cough and dyspnoea had 
dramatically decreased.
Exogenous LP is an inflammatory parenchymal 
condition in response to inhalation or aspiration 
of oil-based substances [1–5]. LP may occur 
in subjects that use substances to treat 
rhinopharyngeal dryness, tracheostomised 
patients who use endotracheal tube lubrication 
oils, and patients with chronic use of nasal sprays 
and decongestants containing mineral oils, 
mainly children and the elderly [6, 7]. The degree 
of tissue damage and the consequent severity of 
this clinical situation are variable and depends 
on the amount, the frequency and the duration 
of inhalation and the chemical properties of the 
oil itself. In the setting of chronic, low-grade 
aspiration patients may present with no symptoms 
and incidentally noted abnormal imaging findings. 
Patients may also present with chronic cough 
or progressively worsening dyspnoea. Rarely, 
LP is characterised by an acute onset because 
of inhalation of large amount of oil substances, 
which can also be fatal. The CT scan is mandatory 
for the diagnosis, showing negative adipose 
density (between −150 and −30 HU) within the 
parenchymal consolidations, with a predilection 
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for the lower lobes: the differential includes other 
fat-containing benign and malignant lesions. In 
some cases, the radiological findings consist of 
ground-glass, crazy-paving type areas with or 
without associated parenchymal consolidation 
of normal density [8, 9]. Bronchiectasis and 
fibrosis may characterise the advanced stages, 
as the result of unrecognised cases. PET-CT 
can lead to misleading signs because of the 
occurrence of pathological uptake secondary 
to the inflammatory component of LP. The 
diagnosis is confirmed by the BAL and cytological 
examination which show a differential cell count 
consisting mainly of alveolar macrophages 
with large intracytoplasmic vacuoles full of 
fat material. The histological examination of a 
transbronchial biopsy may be diagnostic, as in 
the current case, revealing inflammatory cells 
and foamy macrophages containing fat material. 
Diagnosis is sometimes only formulated post-
mortem, when an autopsy is performed and lipid 
material is discovered in the alveoli.
When the diagnosis is posed, the elective 
treatment must obviously involve the 
discontinuation of the aetiological factor, 
supplemental oxygen, broad spectrum antibiotic 
and corticosteroid therapy. There is no specific 
treatment for this condition, and all of the above 
answers may be correct. In literature, the use of 
repeated BALs as a therapeutic strategy has also 
been described to remove the caseous material; in 
some cases, immunoglobulins have been used as a 
therapeutic option [10–14]. Most patients typically 
recover over a period of days with supportive care. 
An emerging form of LP is associated with the 
increasingly widespread use of electronic cigarettes 
(e-cigarettes). Electronic vaping pens/e-cigarettes 
with refillable chambers or interchangeable 
cartridges that contain tetrahydrocannabinol vaping 
concentrates or oils, the principal component of 
cannabis, are most frequently involved in the 
development of this pathological condition [15, 16].
Conclusion
Larygectomised patients may use a variety of 
inappropriate tools for tracheostomy cleaning, 
which may cause complications. There is a wide 
spectrum of causes for exogenous LP which are 
often characterised by late diagnosis. The clinical 
appearances range from acute forms, in which the 
identification of the exposure to the risk factor helps 
to reach the diagnosis, to subacute or chronic ones 
where the hidden history or the underestimation of 
symptoms and radiological findings lead to a delay 
in diagnosis. The radiological manifestations vary 
according to the clinical picture and the stage of the 
disease, ranging from indirect signs of bronchial or 
peribronchial inflammation, to the more complex 
pictures of ground glass or fibrosis. Therefore, the 
clinician must be aware of this condition to activate 
appropriate procedures and to establish the best 
therapeutic approach. This is becoming urgent with 
the widespread use of e-cigarettes that have been 
recently demonstrated to be an important cause 
of LP [15, 16].
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